Variant report
Variant | nsv961762 |
---|---|
Chromosome Location | chr2:67327162-67335344 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199933926 | chr2:67334022-67334023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572802874 | chr2:67334086-67334087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545165663 | chr2:67334091-67334092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564871260 | chr2:67334131-67334132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568720378 | chr2:67334233-67334234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112037049 | chr2:67334234-67334235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544905014 | chr2:67334285-67334286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17033086 | chr2:67334326-67334327 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs1921294 | chr2:67334338-67334339 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs139065572 | chr2:67334377-67334378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs6719951 | chr2:67334411-67334412 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs184072594 | chr2:67334455-67334456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370532124 | chr2:67334490-67334491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532459661 | chr2:67334505-67334506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552643043 | chr2:67334588-67334589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552298229 | chr2:67334611-67334612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34817235 | chr2:67334649-67334650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147507030 | chr2:67334659-67334660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144902082 | chr2:67334660-67334661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143024483 | chr2:67334727-67334728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537880898 | chr2:67334740-67334741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554558307 | chr2:67334755-67334756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567419537 | chr2:67334764-67334765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536549178 | chr2:67334791-67334792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552849989 | chr2:67334820-67334821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573042297 | chr2:67334849-67334850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187217330 | chr2:67334858-67334859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75320667 | chr2:67334873-67334874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193164886 | chr2:67334906-67334907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575429469 | chr2:67334913-67334914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185520226 | chr2:67334935-67334936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560944966 | chr2:67334937-67334938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35017466 | chr2:67334950-67334951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368227138 | chr2:67334975-67334976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34133543 | chr2:67334980-67334981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530291311 | chr2:67334998-67334999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540960048 | chr2:67335011-67335012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560514904 | chr2:67335032-67335033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150815742 | chr2:67335077-67335078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558310783 | chr2:67335083-67335084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139626867 | chr2:67335193-67335194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568975907 | chr2:67335214-67335215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531712389 | chr2:67335215-67335216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190836445 | chr2:67335221-67335222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548241921 | chr2:67335264-67335265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs568449701 | chr2:67335272-67335273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:67326200-67327200 | Enhancers | Colon Smooth Muscle | Colon |
2 | chr2:67334000-67334200 | Enhancers | Fetal Lung | lung |
3 | chr2:67334200-67334800 | Weak transcription | Fetal Lung | lung |
4 | chr2:67334800-67335400 | Enhancers | Fetal Lung | lung |
5 | chr2:67334800-67335600 | Enhancers | Colon Smooth Muscle | Colon |
6 | chr2:67335000-67335400 | Enhancers | Rectal Smooth Muscle | rectum |